Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALEG Syrup versus albendazole for intestinal parasitic infections in children
PACTR202510869237604Phase 2Not yet recruiting
- Sponsor
- Health Sciences Research Institute
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of albendazole in gastrointestinal parasitism and Helminthiases (2 arms), sponsored by Health Sciences Research Institute. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
albendazole
03
Conditions
gastrointestinal parasitismHelminthiases
Beyond the preview
Go deeper on PACTR202510869237604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510869237604.